Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Human Mutation, 33, 4, S. 690-702
- Event
-
Veröffentlichung
- (where)
-
Augsburg, New York, NY
- (who)
-
Universität Augsburg, Wiley-Liss
- (when)
-
2012
- Creator
- DOI
-
10.1002/humu.22025
- URN
-
urn:nbn:de:bvb:384-opus4-844048
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:46 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ramus, S. J.
- Antoniou, A. C.
- Ditsch, Nina
- Universität Augsburg, Wiley-Liss
Time of origin
- 2012
Other Objects (12)
Germline RAD51C mutations confer susceptibility to ovarian cancer
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Ovarian cancer
Ovarian cancer
PET-CT in recurrent ovarian cancer: impact on treatment planning
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Ovarian cancer proteomics
P53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival
Loss of BRCA1 promoter hypermethylation in recurrent high-grade ovarian cancer
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Germline RAD51C mutations confer susceptibility to ovarian cancer
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Ovarian cancer
Ovarian cancer
PET-CT in recurrent ovarian cancer: impact on treatment planning
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Ovarian cancer proteomics
P53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival
Loss of BRCA1 promoter hypermethylation in recurrent high-grade ovarian cancer
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Germline RAD51C mutations confer susceptibility to ovarian cancer
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Ovarian cancer
Ovarian cancer
PET-CT in recurrent ovarian cancer: impact on treatment planning
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Ovarian cancer proteomics
P53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival
Loss of BRCA1 promoter hypermethylation in recurrent high-grade ovarian cancer